DWM
ALNY icon

Dogwood Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Dogwood Wealth Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.03K Buy
30
+17
+131% +$5.13K ﹤0.01% 408
2026
Q1 		$4.3K Sell
13
-18
-58% -$6.13K ﹤0.01% 510
2025
Q4 		$12.3K Buy
31
+11
+55% +$4.87K 0.01% 266
2025
Q3 		$9.12K Hold
20
– – ﹤0.01% 290
2025
Q2 		$6.35K Buy
20
+18
+900% +$4.98K ﹤0.01% 374
2025
Q1 		$540 Buy
+2
New +$514 ﹤0.01% 454
2024
Q3 		– Hold
0
– – – 345
2024
Q2 		– Hold
0
– – – 414
2024
Q1 		– Hold
0
– – – 451
2023
Q4 		– Hold
0
– – – 440

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dogwood Wealth Management's ALNY Position: Q2 2026 in Review

Dogwood Wealth Management increased its Alnylam Pharmaceuticals (ALNY) stake by 131% in Q2 2026, buying an estimated $5.13K and bringing the position to 30 shares worth $9.03K. The position accounts for ﹤0.01% of the portfolio, ranked #408.

Dogwood Wealth Management first reported a position in ALNY in Q1 2025 and has held it in 6 quarters since. The position peaked at $12.3K in Q4 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Dogwood Wealth Management held 30 shares of Alnylam Pharmaceuticals worth $9.03K as of Q2 2026.
  • Dogwood Wealth Management bought 17 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $5.13K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Dogwood Wealth Management's portfolio in Q2 2026, its #408 holding.
  • Dogwood Wealth Management first reported a position in Alnylam Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Dogwood Wealth Management's Alnylam Pharmaceuticals position peaked at $12.3K in Q4 2025.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.